Cytovance Biologics News and Resources

Cytovance Biologics and PolyPeptide have entered into a strategic collaboration to support the development and manufacturing of microbial and mammalian-expressed peptide drugs. This partnership combines Cytovance’s experience in process development and cGMP manufacturing with PolyPeptide’s expertise in complex peptide synthesis,

Cytovance Biologics and Celltheon have announced a partnership to meet the growing demand for complex biologics development and manufacturing in the US. This collaboration integrates Celltheon’s CHO-K1-based cell line development platform with Cytovance’s CDMO services. Axel Schleyer, CCO of Cytovance,